Figure 5.

Assessment of the PMNPs risk model. (A) Univariate and multivariate Cox analyses of clinical factors and risk score with OS. (B) Nomogram estimating the survival rates at 1 and 3 years for patients with PAAD. (C) Calibration chart to confirm the accuracy of the nomogram. (D,E) The DCA curve revealed the clinical net benefit of the constructed model in the TCGA cohort. CI, confidence interval; DCA, decision curve analysis; HR, hazard ratio; M, metastasis; MNPs, microplastics and nanoplastics; N, node; OS, overall survival; PAAD, pancreatic ductal adenocarcinoma; PMNPs, MNPs-related genes in PAAD; T, tumor; TCGA, The Cancer Genome Atlas.